← Open Payments lookup

LISA BOYD: Open Payments

NPI 1306025218 · CONROE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$752 in 13 payments from 10 companies in 2025. Trend: 2023 $815 · 2024 $864 · 2025 $752

Food & beverage: $752
CompanyPaymentsAmount
Axsome Therapeutics, Inc.4$167
ABBVIE INC.1$125
Otsuka America Pharmaceutical, Inc.1$123
Alkermes, Inc.1$122
Neurocrine BioSciences, Inc.1$120
OWP Pharmaceuticals, Inc.1$24
ACADIA Pharmaceuticals Inc1$23
Vanda Pharmaceuticals Inc.1$18
Noven Therapeutics, LLC1$16
Bausch Health US, LLC1$14

Products named: Auvelity, VRAYLAR, LYBALVI, INGREZZA, Subvenite, NUPLAZID, HETLIOZ, Xelstrym.

Industry payments across TX — which companies pay providers there.